Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

Biogen and CV Therapeutics codevelop cardiovascular therapy

March 11, 1997

Na+/K+-exchange inhibitors from Merck KGaA

March 11, 1997

Merck KGaA's new ET antagonists

March 11, 1997

Prostaglandin derivatives from Ono

March 11, 1997

Potent, long-acting ETA antagonist described by Zeneca

March 10, 1997

Merck KGaA discloses ET antagonists

March 10, 1997

OXIS completes preclinicals of restenosis treatment

March 7, 1997

Watson's mexiletine approved

March 6, 1997

Dual NEP/ECE inhibitor for heart failure

March 6, 1997

Potential agent for hypertension and CHF from Roche Bioscience

March 6, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 28, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Feb. 28, 2025
Roche looks to grow with sequencing by expansion tech
BioWorld MedTech
Roche Holding AG revealed plans to launch its sequencing by expansion technology next year, raising the possibility that rival Illumina Inc. could face a real run...
Clots and metastasis in cancer patients start in the lung
BioWorld MedTech
The lung and thrombosis may play a key role in cancer and metastasis progression, according to a collaborative study led by Cornell University scientists. In the...
Evo 2 AI allows genome and epigenome modeling of all life domains
BioWorld MedTech
A new version of Evo, the AI developed at the Arc Institute that can be used to design genomes as long as that of a bacterium, has been retrained with the DNA...